THE CHEMOURS COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.37 USD | -0.15% |
|
-4.14% | -16.39% |
| Apr. 10 | North American Morning Briefing : Traders Await -2- | DJ |
| Apr. 09 | BMO Capital Upgrades Chemours to Outperform From Underperform, Raises Price Target to $34 From $19 | MT |
Financials (USD)
| Sales 2024 * | 5.85B | Sales 2025 * | 6.43B | Capitalization | 3.93B |
|---|---|---|---|---|---|
| Net income 2024 * | 247M | Net income 2025 * | 532M | EV / Sales 2024 * | 1.2 x |
| Net Debt 2024 * | 3.07B | Net Debt 2025 * | 2.98B | EV / Sales 2025 * | 1.07 x |
| P/E ratio 2024 * |
16.3
x | P/E ratio 2025 * |
7.68
x | Employees | 6,200 |
| Yield 2024 * |
4.74% | Yield 2025 * |
4.99% | Free-Float | 74.81% |
More Fundamentals
* Assessed data
More news
Latest transcript on The Chemours Company
More recommendations
More press releases
| 1 day | -0.15% | ||
| 1 week | -3.41% | ||
| Current month | +0.42% | ||
| 1 month | -5.14% | ||
| 3 months | -10.15% | ||
| 6 months | +2.25% | ||
| Current year | -16.39% |
1 week
25.64
27.19
1 month
24.2429.07
Current year
15.1032.70
1 year
15.1039.05
3 years
15.1044.95
5 years
7.0244.95
10 years
3.0658.08
| Managers | Title | Age | Since |
|---|---|---|---|
Denise Dignam
CEO | Chief Executive Officer | 58 | 14-12-31 |
Matthew Abbott
DFI | Director of Finance/CFO | 48 | 16-12-31 |
Brandon Ontjes
IRC | Investor Relations Contact | - | 15-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mary Cranston
BRD | Director/Board Member | 76 | 15-06-18 |
Curtis Anastasio
BRD | Director/Board Member | 67 | 15-06-18 |
Sean Keohane
BRD | Director/Board Member | 56 | 17-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.46% | 3,524 M€ | +3.74% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-17 | 26.37 | -0.15% | 1,147,005 |
| 24-04-16 | 26.41 | +1.50% | 1,336,335 |
| 24-04-15 | 26.02 | -1.74% | 982,304 |
| 24-04-12 | 26.48 | -3.00% | 736,567 |
| 24-04-11 | 27.3 | -0.76% | 821,059 |
Delayed Quote Nyse, April 17, 2024 at 04:00 pm EDT
More quotes
The Chemours Company is a provider of performance chemicals, which is engaged in providing customized solutions with a range of industrial and specialty chemicals products for markets. Its segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. Titanium Technologies segment is a provider of titanium dioxide pigment, a premium white pigment used to deliver whiteness, brightness, opacity, and protection in various applications. The Thermal & Specialized Solutions segment is a provider of refrigerants, thermal management solutions, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment is a provider of high-end polymers and advanced materials. The Company operates in approximately 29 production facilities located in over nine countries and serves approximately 2,900 customers across a range of end markets in approximately 120 countries.
Sector
Diversified Chemicals
Calendar
2024-04-28
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
26.41
USD
Average target price
31.44
USD
Spread / Average Target
+19.06%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -16.39% | 3.93B | |
| +7.52% | 81.61B | |
| +4.49% | 47.93B | |
| -4.99% | 30.34B | |
| +6.04% | 17.5B | |
| -9.71% | 11.57B | |
| +6.85% | 11.34B | |
| +5.63% | 9.96B | |
| -7.11% | 9.81B | |
| +1.52% | 8.92B |
- Stock Market
- Equities
- CC Stock
